Your Browser Is No Longer Supported. Please upgrade your browser from Internet Explorer 10 to Internet Explorer 11 or higher
SHM has submitted comments on the COVID–19 Public Health Emergency interim final rule to CMS. SHM has voiced our support for many of the waivers and flexibilities issued for the duration of the
SHM signed a multi-stakeholder letter to the Department of Health and Human Services (HHS). The letter urges HHS, in light of COVID-19 financial losses, to utilize its authority under the Public
SHM sent a letter to members of the Senate Finance Committee, the House Ways and Means Committee, and the House Energy and Commerce Committee regarding proposed payment adjustments and budget
SHM joins the American College of Physicians (ACP) and other subspecialties in expressing our concern over the upcoming compliance deadlines included in the "Patient Access" rule.
SHM joined a multi-stakeholder letter to CMS regarding proposals related to the Merit-based Incentive Payment System (MIPS) Value Pathway (MVP) proposals. Specifically, the letter urges CMS to
SHM joined a multi-stakeholder letter urging the extension of telehealth flexibilities beyond the expiration of the PHE.
SHM has joined a multi-stakeholder letter to CMS, urging the agency to halt the implementation of their new split/shared billing policy,
SHM joined the AMA and other medical specialty societies, urging CMS to rescind the new policy on split (or shared) billing.
SHM submitted comments on the quality and performance measurement provisions of the 2023 IPPS proposed rule and responded to a Request for Information on measuring healthcare disparities.
On January 12, 2023, the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) announced the immediate elimination of the X-Waiver for